Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Sanofi
Biotech
Sanofi pays Regeneron $1B for 4 early-stage assets to ignite R&D
The deal, which features $7 billion in milestones, tees the longstanding partners up to try to replicate Dupixent’s success.
Nick Paul Taylor
Oct 1, 2026 4:24am
Owkin, Servier ink oncology trial and discovery deal
Sep 11, 2026 2:01pm
A year after Big Pharma’s pull-back from the UK, what’s changed?
Sep 4, 2026 10:00am
Electra aims to light up Nasdaq with IPO for phase 2/3 I&I push
Aug 31, 2026 11:27am
Sanofi suspends chronic lung disease phase 2 study
Aug 5, 2026 2:50pm
Sanofi CEO ‘looking deeply’ at pipeline as clearout continues
Jul 30, 2026 3:27am
